NHL patients with high s-IL6 levels, advanced age, elevated ESR, high beta-2 microglobulin, poor ECOG performance, and high IPI scores had a shorter duration of life and poorer prognosis. This evidence concerns the gene IL6 and non-Hodgkin lymphoma.